Catalyst Wire Dossier Catalyst Wire Dossier

GLA5PR GLARS-NF1 Tab.

· Daewon Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GLA5PR GLARS-NF1 Tab., covering 2019-03-19 to 2019-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of 'GLA5PR GLARS-NF1 Tab.' in Peripheral Neuropathic Pain [Phase 3]

See pricing